Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Convertible Debt (2016 - 2025)

Historic Convertible Debt for Integra Lifesciences Holdings (IART) over the last 16 years, with Q3 2025 value amounting to $83.5 million.

  • Integra Lifesciences Holdings' Convertible Debt rose 1469.78% to $83.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.5 million, marking a year-over-year increase of 1469.78%. This contributed to the annual value of $108.1 million for FY2024, which is 8104.36% down from last year.
  • Per Integra Lifesciences Holdings' latest filing, its Convertible Debt stood at $83.5 million for Q3 2025, which was up 1469.78% from $108.8 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Convertible Debt registered a high of $571.7 million during Q2 2024, and its lowest value of $72.8 million during Q3 2024.
  • For the 5-year period, Integra Lifesciences Holdings' Convertible Debt averaged around $442.8 million, with its median value being $565.2 million (2022).
  • Per our database at Business Quant, Integra Lifesciences Holdings' Convertible Debt soared by 53347.47% in 2021 and then crashed by 8721.75% in 2024.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Convertible Debt stood at $564.4 million in 2021, then grew by 0.52% to $567.3 million in 2022, then increased by 0.51% to $570.3 million in 2023, then tumbled by 81.04% to $108.1 million in 2024, then fell by 22.76% to $83.5 million in 2025.
  • Its Convertible Debt was $83.5 million in Q3 2025, compared to $108.8 million in Q2 2025 and $102.1 million in Q1 2025.